Evidence map›Paper›PMID 24790089›Full record

ArticleThe Journal of biological chemistry2014

The molecular chaperone HSP70 binds to and stabilizes NOD2, an important protein involved in Crohn disease.

Vishnu Mohanan, Catherine Leimkuhler Grimes

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Role and molecular mechanism of NOD2 in chronic non-communicable diseases.Journal of molecular medicine (Berlin, Germany) · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. NOD Signaling and Cell Death.Frontiers in cell and developmental biology · 2019
    Review
  13. Article
  14. NOD2 and inflammation: current insights.Journal of inflammation research · 2018
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. The effect of NOD2 on the microbiota in Crohn's disease.Current opinion in biotechnology · 2016
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vishnu MohananFrom the Departments of Biological Sciences and.
Catherine Leimkuhler GrimesFrom the Departments of Biological Sciences and Chemistry and Biochemistry, University of Delaware, Newark, Delaware 19716 cgrimes@udel.edu.
University of Delaware · US

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Anjana Narayan Bhat · 2012 to 2026
$67.2M
Molecular Design of Advanced BiomaterialsP20GM103541 · NIGMS · UNIVERSITY OF DELAWARE · PI POLENOVA, TATYANA · 2012 to 2012
$2.1M
NIGMS NIH HHS 8 P20GM103446-13NIGMS NIH HHS P20 GM103446NIGMS NIH HHS P20 GM103541NIGMS NIH HHS P20GM103541
6 · The paper itself

Abstract

Microbes are detected by the pathogen-associated molecular patterns through specific host pattern recognition receptors. Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is an intracellular pattern recognition receptor that recognizes fragments of the bacterial cell wall. NOD2 is important to human biology; when it is mutated it loses the ability to respond properly to bacterial cell wall fragments. To determine the mechanisms of misactivation in the NOD2 Crohn mutants, we developed a cell-based system to screen for protein-protein interactors of NOD2. We identified heat shock protein 70 (HSP70) as a protein interactor of both wild type and Crohn mutant NOD2. HSP70 has previously been linked to inflammation, especially in the regulation of anti-inflammatory molecules. Induced HSP70 expression in cells increased the response of NOD2 to bacterial cell wall fragments. In addition, an HSP70 inhibitor, KNK437, was capable of decreasing NOD2-mediated NF-κB activation in response to bacterial cell wall stimulation. We found HSP70 to regulate the half-life of NOD2, as increasing the HSP70 level in cells increased the half-life of NOD2, and down-regulating HSP70 decreased the half-life of NOD2. The expression levels of the Crohn-associated NOD2 variants were less compared with wild type. The overexpression of HSP70 significantly increased NOD2 levels as well as the signaling capacity of the mutants. Thus, our study shows that restoring the stability of the NOD2 Crohn mutants is sufficient for rescuing the ability of these mutations to signal the presence of a bacterial cell wall ligand.

Indexed as

Acetylmuramyl-Alanyl-IsoglutamineAnimalsCell WallCrohn DiseaseGene Expression RegulationHalf-LifeHCT116 CellsHEK293 CellsHSP70 Heat-Shock ProteinsHumansMutationNF-kappa BNod2 Signaling Adaptor ProteinProtein BindingProtein StabilitySignal TransductionAcetylmuramyl-Alanyl-IsoglutamineHSP70 Heat-Shock ProteinsNF-kappa BNod2 Signaling Adaptor ProteinTetracyclineCell WallHSP70Innate ImmunityMuramyl DipeptideNF-κBNOD2Nod-like ReceptorPeptidoglycanSignal Transduction

Identifiers

PMID24790089
PMCPMC4081938
OpenAlexW1974101555

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.